3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
11
Anemia, Refractory, with Excess of Blasts
11
Neoplasms
9
Myelodysplastic Syndromes
8
Venous Thromboembolism
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Anemia, Aplastic
5
Myeloproliferative Disorders
4
Lymphoma, Non-Hodgkin
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Hematologic Neoplasms
4
Fanconi Anemia
4
Anemia
4
Pulmonary Embolism
3
Primary Myelofibrosis
3
Myelodysplastic-Myeloproliferative Diseases
3
Multiple Myeloma
3
Leukemia, Myeloid, Accelerated Phase
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Hodgkin Disease
3
Congenital Bone Marrow Failure Syndromes
3
Burkitt Lymphoma
3
Blast Crisis
3
Anemia, Sickle Cell
3
Venous Thrombosis
2
Recurrence
2
Neutropenia
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hemorrhage
×
Classical hematology
×
30 days
×
Clear all
NCT07410117
2026-05-27
ROXI-CAT-I
Regeneron Pharmaceuticals
Phase 3
Recruiting
1,120 enrolled